Burning Rock Biotech Ltd (BNR) — Institutional Holders, Q2 2026
17 institutional investment managers reported a BNR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $14.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BNR in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MORGAN STANLEYAdded · +28,322 sh+$237.1K
- UBS Group AGAdded · +17,508 sh+$146.5K
- RENAISSANCE TECHNOLOGIESAdded · +17,431 sh+$145.9K
- Almanack Investment PartnersNew · +16,198 sh+$135.6K
- XTX Topco LtdNew · +13,621 sh+$114.0K
Biggest sellers
- CRCMTrimmed · -70,100 sh-$586.7K
- Sumitomo MitsuiTrimmed · -413 sh-$3.5K
- Nikko Asset Management AmericasTrimmed · -413 sh-$3.5K
- JPMORGAN CHASETrimmed · -21 sh-$176.00
- CITIGROUPSold out · -1 sh-$8.00
BNR 13F holders ranked 1–17 of 17
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Kynam Capital Management#1 · 1,238,563 sh | 1,238,563 | $10.5M | 0.58% | +0.9% |
| 2 | CRCM#2 · 211,997 sh | 211,997 | $1.8M | 1.23% | -24.8% |
| 3 | RENAISSANCE TECHNOLOGIES#3 · 52,838 sh | 52,838 | $442.3K | <0.01% | +49.2% |
| 4 | MORGAN STANLEY#4 · 43,594 sh | 43,594 | $364.9K | 0.00% | +185.5% |
| 5 | Nikko Asset Management Americas#5 · 29,724 sh | 29,724 | $257.7K | <0.01% | -1.4% |
| 6 | Sumitomo Mitsui#6 · 29,724 sh | 29,724 | $248.8K | <0.01% | -1.4% |
| 7 | BANK OF AMERICA#7 · 29,164 sh | 29,164 | $244.1K | 0.00% | 0.0% |
| 8 | CITADEL ADVISORS#8 · 27,288 sh | 27,288 | $236.6K | 0.00% | +54.4% |
| 9 | SC CHINA HOLDING Ltd#9 · 21,212 sh | 21,212 | $177.5K | 0.01% | 0.0% |
| 10 | UBS Group AG#10 · 17,916 sh | 17,916 | $150.0K | 0.00% | +4291.2% |
| 11 | Almanack Investment Partners#11 · 16,198 sh | 16,198 | $135.6K | 0.02% | New |
| 12 | XTX Topco Ltd#12 · 13,621 sh | 13,621 | $118.1K | <0.01% | New |
| 13 | BNP PARIBAS FINANCIAL MARKETS#13 · 2,800 sh | 2,800 | $23.4K | 0.00% | 0.0% |
| 14 | Tower Research Capital (TRC)#14 · 1,242 sh | 1,242 | $10.4K | <0.01% | +4335.7% |
| 15 | JPMORGAN CHASE#15 · 166 sh | 166 | $1.3K | 0.00% | -11.2% |
| 16 | ROYAL BANK OF CANADA#16 · 73 sh | 73 | $1.0K | 0.00% | New |
| 17 | BlackRock#17 · 4 sh | 4 | $33.00 | 0.00% | 0.0% |
Funds that sold out of BNR in Q2 2026 (1)
Held BNR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| CITIGROUP1 sh | 1 | $16.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.